<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04137705</url>
  </required_header>
  <id_info>
    <org_study_id>CA0080</org_study_id>
    <nct_id>NCT04137705</nct_id>
  </id_info>
  <brief_title>MultiOrgan Multi-Parametric MRI Study</brief_title>
  <acronym>MORIS</acronym>
  <official_title>MultiOrgan Multi-Parametric MRI Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Perspectum</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Perspectum</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the reproducibility of a single quantitative multiparametric MRI for the&#xD;
      assessment of body composition and multiple organ structures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 4, 2019</start_date>
  <completion_date type="Anticipated">November 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 25, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of repeatability (precision under the same conditions in the same subjects: 2 separate MRI acquisitions on the same scanner) of body composition and multiple organ metrics.</measure>
    <time_frame>24 months</time_frame>
    <description>To determine the repeatability of multiparametric MRI in the assessment of body composition and multiple organ structures obtained within a single MR scanning session (liver, pancreas, aorta, kidney and spleen)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of the reproducibility (precision under different measurement conditions: same participants scanned on separate MRI scanners at both 1.5T and 3T) of multiparametric MRI for the assessment of body composition and multiple organ metrics.</measure>
    <time_frame>24 months</time_frame>
    <description>To determine the reproducibility of multiparametric MRI in the assessment of body composition and multiple organ structures (liver, pancreas, aorta, kidney and spleen) obtained within separate MR scanning sessions.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Assessment of the mean differences in body composition and multiple organ metrics between healthy participants and those with type 2 diabetes acquired with multiparametric MRI.</measure>
    <time_frame>24 months</time_frame>
    <description>To determine the range of body composition and multi-organ metrics (liver, pancreas, aorta, kidney and spleen) in healthy participants and in those with type 2 diabetes assessed using multiparametric MRI.</description>
  </other_outcome>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Type 2 Diabetes</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multiparametric MRI</intervention_name>
    <description>A standardised MRI protocol that provides a number of quantitative metrics on liver and other organs relevant to type 2 Diabetes - pancreas, kidneys, spleen and aorta</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult volunteers, including healthy volunteers and individuals with Type 2 Diabetes (T2D).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any person over 18 years of age.&#xD;
&#xD;
          -  Participant is willing and able to give informed consent for participation in the&#xD;
             investigation.&#xD;
&#xD;
          -  EITHER: Participant has Type 2 Diabetes OR: Person is a healthy volunteer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The participant may not enter the investigation if they have any contraindication to&#xD;
             magnetic resonance imaging (incl. pregnancy, extensive tattoos, pacemaker, shrapnel&#xD;
             injury, severe claustrophobia).&#xD;
&#xD;
          -  Any other cause, including a significant disease or disorder which, in the opinion of&#xD;
             the investigator, may either put the participant at risk because of participation in&#xD;
             the investigation, or may influence the result of the investigation, or the&#xD;
             participant's ability to participate in the investigation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Beaver House</name>
      <address>
        <city>Oxford</city>
        <zip>OX1 2EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oxford Centre for Magnetic Resonance</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemini One</name>
      <address>
        <city>Oxford</city>
        <zip>OX4 2LL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 22, 2019</study_first_submitted>
  <study_first_submitted_qc>October 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2019</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

